University Hospital Zurich has in collaboration with the Paul Scherrer Institute for the first time in Switzerland treated an esophageal cancer…

PROTECT is now an active multicenter study, after the first patient has started treatment at the proton therapy center PARTICLE in UZ Leuven, BE.

The first of 396 patients has been enrolled into the PROTECT study with the aim of setting new standards for the clinical use of proton radiotherapy…